Stereotactic Radiosurgery for Brain Arteriovenous Malformations: A Radiosurgery Society Case-Based Guide
Practical Radiation Oncology · 2026-11 · 16 (6) · 574-585
DOI: 10.1016/j.prro.2026.04.001 ↗Kurz gefasst
Fallbericht in der Zeitschrift Practical Radiation Oncology, 2026-11. Verfasst von Rojine T Ariani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, California. Electronic address: rariani@mednet.ucla.edu. Hauptthemen laut MEDLINE: Radiosurgery, Intracranial Arteriovenous Malformations. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Radiation Oncology Institute, Accuray, Brainlab.
Abstract (Originalsprache)
PURPOSE: Brain arteriovenous malformations (AVMs) are high-risk vascular anomalies associated with hemorrhage, neurological morbidity, and mortality. Stereotactic radiosurgery (SRS) is a well-established, noninvasive treatment that achieves durable obliteration while preserving neurological function. This case-based guideline summarizes contemporary SRS-based AVM management and outcomes. METHODS AND MATERIALS: Three illustrative cases were selected: a small, unruptured Spetzler-Martin grade (SMG) I AVM treated with single-fraction SRS, a large SMG V AVM managed with volume-staged SRS, and a ruptured SMG II AVM treated with embolization followed by definitive SRS. RESULTS: Single-fraction SRS achieves durable obliteration for small AVMs, whereas staged approaches allow safe treatment of large or complex lesions and complement microsurgery and embolization. Treatment planning emphasizes integration of advanced imaging, precise nidus delineation, and dose-volume optimization. Long-term surveillance remains essential to confirm obliteration and detect delayed complications. CONCLUSIONS: This case-based guideline highlights practical principles of SRS for brain AVM management, emphasizing individualized selection, multidisciplinary collaboration, and meticulous planning to optimize safety and efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, California. Electronic address: rariani@mednet.ucla.edu.
- Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, California.
- Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
- Charité - Universitätsmedizin Berlin, Department of Radiation Oncology, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité - Universitätsmedizin Berlin, Berlin,…
- Department of Radiation Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, New York.
- Department of Radiation Oncology, Ohio State University, Columbus, Ohio.
Förderung
- Radiation Oncology Institute
- Accuray
- Brainlab
Zitieren
APA
Ariani, R. T., Liu, E. Y., Goulenko, V., Courtney, P. T., Ehret, F., Skalina, K. A., Fekrmandi, F., Kaprealian, T., Tenn, S., Savjani, R. R., Prasad, D., & Schulder, M. (2026). Stereotactic Radiosurgery for Brain Arteriovenous Malformations: A Radiosurgery Society Case-Based Guide. Practical Radiation Oncology, 16(6), 574-585. https://doi.org/10.1016/j.prro.2026.04.001
Vancouver
Ariani RT, Liu EY, Goulenko V, Courtney PT, Ehret F, Skalina KA, et al. Stereotactic Radiosurgery for Brain Arteriovenous Malformations: A Radiosurgery Society Case-Based Guide. Practical Radiation Oncology. 2026;16(6):574-585. doi:10.1016/j.prro.2026.04.001
BibTeX
@article{Ariani2026,
author = {Ariani, Rojine T and Liu, Eulanca Y and Goulenko, Victor and Courtney, Patrick Travis and Ehret, Felix and Skalina, Karin A and Fekrmandi, Fatemeh and Kaprealian, Tania and Tenn, Stephen and Savjani, Ricky R and Prasad, Dheerendra and Schulder, Michael},
title = {Stereotactic Radiosurgery for Brain Arteriovenous Malformations: A Radiosurgery Society Case-Based Guide},
journal = {Practical Radiation Oncology},
year = {2026},
volume = {16},
number = {6},
pages = {574--585},
doi = {10.1016/j.prro.2026.04.001}
}
EUVIMED